Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Journal of Hematology & Oncology,
Journal Year:
2025,
Volume and Issue:
18(1)
Published: Jan. 13, 2025
The
tumor
microenvironment
(TME)
is
integral
to
cancer
progression,
impacting
metastasis
and
treatment
response.
It
consists
of
diverse
cell
types,
extracellular
matrix
components,
signaling
molecules
that
interact
promote
growth
therapeutic
resistance.
Elucidating
the
intricate
interactions
between
cells
TME
crucial
in
understanding
progression
challenges.
A
critical
process
induced
by
epithelial-mesenchymal
transition
(EMT),
wherein
epithelial
acquire
mesenchymal
traits,
which
enhance
their
motility
invasiveness
progression.
By
targeting
various
components
TME,
novel
investigational
strategies
aim
disrupt
TME's
contribution
EMT,
thereby
improving
efficacy,
addressing
resistance,
offering
a
nuanced
approach
therapy.
This
review
scrutinizes
key
players
emphasizing
avenues
therapeutically
components.
Moreover,
article
discusses
implications
for
resistance
mechanisms
highlights
current
toward
modulation
along
with
potential
caveats.
Language: Английский
Epigenetic Regulation of Stromal and Immune Cells and Therapeutic Targets in the Tumor Microenvironment
Kang Liu,
No information about this author
Yue Li,
No information about this author
Minmin Shen
No information about this author
et al.
Biomolecules,
Journal Year:
2025,
Volume and Issue:
15(1), P. 71 - 71
Published: Jan. 6, 2025
The
tumor
microenvironment
(TME)
plays
a
pivotal
role
in
neoplastic
initiation
and
progression.
Epigenetic
machinery,
governing
the
expression
of
core
oncogenes
suppressor
genes
transformed
cells,
significantly
contributes
to
development
at
both
primary
distant
sites.
Recent
studies
have
illuminated
how
epigenetic
mechanisms
integrate
external
cues
downstream
signals,
altering
phenotype
stromal
cells
immune
cells.
This
remolds
area
surrounding
ultimately
fostering
an
immunosuppressive
microenvironment.
Therefore,
correcting
TME
by
targeting
modifications
holds
substantial
promise
for
cancer
treatment.
review
synthesizes
recent
research
that
elucidates
impact
specific
regulations-ranging
from
DNA
methylation
histone
chromatin
remodeling-on
within
TME.
Notably,
we
highlight
their
functional
roles
either
promoting
or
restricting
We
also
discuss
potential
applications
agents
treatment,
envisaging
ability
normalize
ecosystem.
aims
assist
researchers
understanding
dynamic
interplay
between
epigenetics
TME,
paving
way
better
therapy.
Language: Английский
Formononetin Affects Polarization of M2 Macrophages Through the Jak2/Stat3 Pathway in Hcc
Yan Zhuang,
No information about this author
Shouhong Gao,
No information about this author
Yichao Yan
No information about this author
et al.
Published: Jan. 1, 2025
Language: Английский
Single-cell RNA sequencing reveals cellular and molecular heterogeneity in extensive-stage small cell lung cancer with different chemotherapy responses
Gu Zhan,
No information about this author
Yongqing Heng,
No information about this author
Rui Fan
No information about this author
et al.
Cancer Cell International,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: April 21, 2025
Despite
its
rapid
growth
and
early
metastasis,
small
cell
lung
cancer
(SCLC)
is
more
chemosensitive
than
other
cancers.
However,
some
patients
with
extensive-stage
SCLC
(ES-SCLC)
do
not
respond
to
first-line
chemotherapy,
resulting
in
poorer
prognoses
due
inter-
intratumoral
heterogeneity.
In
this
study,
we
conducted
single-cell
RNA
sequencing
of
9
treatment-naive
ES-SCLC
samples.
Based
on
comprehensive
imaging
evidence
collected
before
after
two
cycles
chemotherapy
sample
types,
the
samples
were
categorized
into
three
groups:
progressive
disease
pleural
effusion
(PD_PE
group,
n
=
1),
primary
tumor
(PD_TU
2),
partial
response
(PR_TU
6).
transcriptomic
landscape
type
composition,
PD
represent
a
multicellular
ecosystem
distinct
from
PR
The
immune
response,
along
elevated
expression
immune-related
genes
such
as
LTF,
SLPI,
SPARC
IGLV1-51,
might
correlate
poor
ES-SCLC.
We
also
observed
that
T
cells,
particularly
effector
abundant
PD_TU
TNFA
signaling
via
NFκB
being
significantly
enriched.
group
was
strongly
enriched
macrophages
tumor-associated
(TAMs),
angiogenesis
TAMs
highly
Immunomodulatory
fibroblasts
pathways
epithelial-mesenchymal
transition
upregulated.
This
study
offers
first
insights
cellular
molecular
heterogeneity
different
responses.
Language: Английский
Mechano-mediated M2 macrophage polarization and immune suppression in stiffened tumor microenvironment
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 29, 2024
Abstract
The
tumor
microenvironment
(TME),
which
is
composed
of
various
cell
types
and
the
extracellular
matrix
(ECM),
plays
crucial
roles
in
cancer
progression
treatment
outcomes.
However,
impact
mechanical
properties
ECM,
specifically
collagen
fibril
alignment
crosslinking,
on
macrophage
behavior
polarization
less
understood.
To
investigate
this,
we
reconstituted
3D
matrices
to
mimic
physical
characteristics
TME.
Our
results
demonstrated
that
stiffening
through
or
crosslinking
fibrils
promotes
toward
anti-inflammatory
M2
phenotype.
This
phenotype
characterized
by
increased
expression
CD105
CD206
a
distinct
cytokine
secretion
profile.
stiffness
aligned
activate
mechanotransduction
pathways,
notably
integrin
β1
PI3K
signaling,
leading
IL-4
secretion,
acts
an
autocrine
manner
further
promote
polarization.
Interestingly,
these
stiffened
microenvironments
also
suppressed
proinflammatory
response.
In
coculture
experiments
with
breast
lines
(MDA-MB-231
MCF-7),
macrophages
within
significantly
proliferation
invasion.
These
findings
suggest
its
create
more
favorable
environment
for
modulating
activity.
Overall,
our
study
underscores
critical
role
ECM
mechanics
shaping
immune
TME,
highlighting
potential
therapies
target
inhibit
enhance
efficacy.
Language: Английский
PPIC-labeled CAFs: Key players in neoadjuvant chemotherapy resistance for gastric cancer
Honghao Yin,
No information about this author
Lili Sun,
No information about this author
Yuan Yuan
No information about this author
et al.
Translational Oncology,
Journal Year:
2024,
Volume and Issue:
48, P. 102080 - 102080
Published: Aug. 7, 2024
Gastric
cancer
(GC)
is
the
fourth
leading
cause
of
deaths,
with
advanced
cases
having
a
median
survival
less
than
one
year.
Neoadjuvant
chemotherapy
(NCT)
vital
but
faces
drug
resistance
issues,
partly
due
to
cancer-associated
fibroblasts
(CAFs).
Yet,
specific
CAF
subpopulations
contributing
are
poorly
understood.
Language: Английский